Association of genomic domains in BRCA1 and BRCA2 with prostate cancer risk and aggressiveness

Show full item record



Permalink

http://hdl.handle.net/10138/325578

Citation

Patel , V L , Busch , E L , Friebel , T M , Cronin , A , Leslie , G , McGuffog , L , Adlard , J , Agata , S , Agnarsson , B A , Ahmed , M , Aittomäki , K , Alducci , E , Andrulis , I L , Arason , A , Arnold , N , Artioli , G , Arver , B , Auber , B , Azzollini , J , Balmaña , J , Barkardottir , R B , Barnes , D R , Barroso , A , Barrowdale , D , Belotti , M , Benitez , J , Bertelsen , B , Blok , M J , Bodrogi , I , Bonadona , V , Bonanni , B , Bondavalli , D , Boonen , S E , Borde , J , Borg , A , Bradbury , A R , Brady , A , Brewer , C , Brunet , J , Buecher , B , Buys , S S , Cabezas-Camarero , S , Caldes , T , Caliebe , A , Caligo , M A , Calvello , M , Campbell , I G , Carnevali , I , Carrasco , E , Chan , T L , Chu , A T W , Chung , W K , Claes , K B M , Cook , J , Cortesi , L , Couch , F J , Daly , M B , Damante , G , Darder , E , Davidson , R , De La Hoya , M , Della Puppa , L , Dennis , J , Díez , O , Ding , Y C , Ditsch , N , Domchek , S M , Donaldson , A , Dworniczak , B , Easton , D F , Eccles , D M , Eeles , R A , Ehrencrona , H , Ejlertsen , B , Engel , C , Evans , D G , Faivre , L , Faust , U , Feliubadalo , L , Foretova , L , Fostira , F , Fountzilas , G , Frost , D , García-Barberan , V , Garre , P , Gauthier-Villars , M , Geczi , L , Gehrig , A , Gerdes , A-M , Gesta , P , Giannini , G , Glendon , G , Godwin , A K , Goldgar , D E , Greene , M H , Gutierrez-Barrera , A M , Hahnen , E , Hamann , U , Hauke , J , Herold , N , Hogervorst , F B L , Honisch , E , Hopper , J L , Hulick , P J , Izatt , L , Jager , A , James , P , Janavicius , R , Jensen , U B , Jensen , T D , Johannsson , O T , John , E M , Joseph , V , Kang , E , Kast , K , Kiiski , J I , Kim , S-W , Kim , Z , Ko , K-P , Konstantopoulou , I , Kramer , G , Krogh , L , Kruse , T A , Kwong , A , Larsen , M , Lasset , C , Lautrup , C , Lazaro , C , Lee , J , Lee , J W , Lee , M H , Lemke , J , Lesueur , F , Liljegren , A , Lindblom , A , Llovet , P , Lopez-Fernandez , A , Lopez-Perolio , I , Lorca , V , Loud , J T , Ma , E S K , Mai , P L , Manoukian , S , Mari , V , Martin , L , Matricardi , L , Mebirouk , N , Medici , V , Meijers-Heijboer , H E J , Meindl , A , Mensenkamp , A R , Miller , C , Gomes , D M , Montagna , M , Mooij , T M , Moserle , L , Mouret-Fourme , E , Mulligan , A M , Nathanson , K L , Navratilova , M , Nevanlinna , H , Niederacher , D , Cilius Nielsen , F C , Nikitina-Zake , L , Offit , K , Olah , E , Olopade , O I , Ong , K-R , Osorio , A , Ott , C-E , Palli , D , Park , S K , Parsons , M T , Pedersen , I S , Peissel , B , Peixoto , A , Perez-Segura , P , Peterlongo , P , Petersen , A H , Porteous , M E , Pujana , M A , Radice , P , Ramser , J , Rantala , J , Rashid , M U , Rhiem , K , Rizzolo , P , Robson , M E , Rookus , M A , Rossing , C M , Ruddy , K J , Santos , C , Saule , C , Scarpitta , R , Schmutzler , R K , Schuster , H , Senter , L , Seynaeve , C M , Shah , P D , Sharma , P , Shin , V Y , Silvestri , V , Simard , J , Singer , C F , Skytte , A-B , Snape , K , Solano , A R , Soucy , P , Southey , M C , Spurdle , A B , Steele , L , Steinemann , D , Stoppa-Lyonnet , D , Stradella , A , Sunde , L , Sutter , C , Tan , Y Y , Teixeira , M R , Teo , S H , Thomassen , M , Tibiletti , M G , Tischkowitz , M , Tognazzo , S , Toland , A E , Tommasi , S , Torres , D , Toss , A , Trainer , A H , Tung , N , Van Asperen , C J , Van Der Baan , F H , Van Der Kolk , L E , Van Der Luijt , R B , Van Hest , L P , Varesco , L , Varon-Mateeva , R , Viel , A , Vierstrate , J , Villa , R , Von Wachenfeldt , A , Wagner , P , Wang-Gohrke , S , Wappenschmidt , B , Weitzel , J N , Wieme , G , Yadav , S , Yannoukakos , D , Yoon , S-Y , Zanzottera , C , Zorn , K K , D’Amico , A V , Freedman , M L , Pomerantz , M M , Chenevix-Trench , G , Antoniou , A C , Neuhausen , S L , Ottini , L , Nielsen , H R & Rebbeck , T R 2020 , ' Association of genomic domains in BRCA1 and BRCA2 with prostate cancer risk and aggressiveness ' , Cancer Research , vol. 80 , no. 3 , pp. 624-638 . https://doi.org/10.1158/0008-5472.CAN-19-1840

Title: Association of genomic domains in BRCA1 and BRCA2 with prostate cancer risk and aggressiveness
Author: Patel, V.L.; Busch, E.L.; Friebel, T.M.; Cronin, A.; Leslie, G.; McGuffog, L.; Adlard, J.; Agata, S.; Agnarsson, B.A.; Ahmed, M.; Aittomäki, K.; Alducci, E.; Andrulis, I.L.; Arason, A.; Arnold, N.; Artioli, G.; Arver, B.; Auber, B.; Azzollini, J.; Balmaña, J.; Barkardottir, R.B.; Barnes, D.R.; Barroso, A.; Barrowdale, D.; Belotti, M.; Benitez, J.; Bertelsen, B.; Blok, M.J.; Bodrogi, I.; Bonadona, V.; Bonanni, B.; Bondavalli, D.; Boonen, S.E.; Borde, J.; Borg, A.; Bradbury, A.R.; Brady, A.; Brewer, C.; Brunet, J.; Buecher, B.; Buys, S.S.; Cabezas-Camarero, S.; Caldes, T.; Caliebe, A.; Caligo, M.A.; Calvello, M.; Campbell, I.G.; Carnevali, I.; Carrasco, E.; Chan, T.L.; Chu, A.T.W.; Chung, W.K.; Claes, K.B.M.; Cook, J.; Cortesi, L.; Couch, F.J.; Daly, M.B.; Damante, G.; Darder, E.; Davidson, R.; De La Hoya, M.; Della Puppa, L.; Dennis, J.; Díez, O.; Ding, Y.C.; Ditsch, N.; Domchek, S.M.; Donaldson, A.; Dworniczak, B.; Easton, D.F.; Eccles, D.M.; Eeles, R.A.; Ehrencrona, H.; Ejlertsen, B.; Engel, C.; Evans, D.G.; Faivre, L.; Faust, U.; Feliubadalo, L.; Foretova, L.; Fostira, F.; Fountzilas, G.; Frost, D.; García-Barberan, V.; Garre, P.; Gauthier-Villars, M.; Geczi, L.; Gehrig, A.; Gerdes, A.-M.; Gesta, P.; Giannini, G.; Glendon, G.; Godwin, A.K.; Goldgar, D.E.; Greene, M.H.; Gutierrez-Barrera, A.M.; Hahnen, E.; Hamann, U.; Hauke, J.; Herold, N.; Hogervorst, F.B.L.; Honisch, E.; Hopper, J.L.; Hulick, P.J.; Izatt, L.; Jager, A.; James, P.; Janavicius, R.; Jensen, U.B.; Jensen, T.D.; Johannsson, O.Th.; John, E.M.; Joseph, V.; Kang, E.; Kast, K.; Kiiski, J.I.; Kim, S.-W.; Kim, Z.; Ko, K.-P.; Konstantopoulou, I.; Kramer, G.; Krogh, L.; Kruse, T.A.; Kwong, A.; Larsen, M.; Lasset, C.; Lautrup, C.; Lazaro, C.; Lee, J.; Lee, J.W.; Lee, M.H.; Lemke, J.; Lesueur, F.; Liljegren, A.; Lindblom, A.; Llovet, P.; Lopez-Fernandez, A.; Lopez-Perolio, I.; Lorca, V.; Loud, J.T.; Ma, E.S.K.; Mai, P.L.; Manoukian, S.; Mari, V.; Martin, L.; Matricardi, L.; Mebirouk, N.; Medici, V.; Meijers-Heijboer, H.E.J.; Meindl, A.; Mensenkamp, A.R.; Miller, C.; Gomes, D.M.; Montagna, M.; Mooij, T.M.; Moserle, L.; Mouret-Fourme, E.; Mulligan, A.M.; Nathanson, K.L.; Navratilova, M.; Nevanlinna, H.; Niederacher, D.; Cilius Nielsen, F.C.; Nikitina-Zake, L.; Offit, K.; Olah, E.; Olopade, O.I.; Ong, K.-R.; Osorio, A.; Ott, C.-E.; Palli, D.; Park, S.K.; Parsons, M.T.; Pedersen, I.S.; Peissel, B.; Peixoto, A.; Perez-Segura, P.; Peterlongo, P.; Petersen, A.H.; Porteous, M.E.; Pujana, M.A.; Radice, P.; Ramser, J.; Rantala, J.; Rashid, M.U.; Rhiem, K.; Rizzolo, P.; Robson, M.E.; Rookus, M.A.; Rossing, C.M.; Ruddy, K.J.; Santos, C.; Saule, C.; Scarpitta, R.; Schmutzler, R.K.; Schuster, H.; Senter, L.; Seynaeve, C.M.; Shah, P.D.; Sharma, P.; Shin, V.Y.; Silvestri, V.; Simard, J.; Singer, C.F.; Skytte, A.-B.; Snape, K.; Solano, A.R.; Soucy, P.; Southey, M.C.; Spurdle, A.B.; Steele, L.; Steinemann, D.; Stoppa-Lyonnet, D.; Stradella, A.; Sunde, L.; Sutter, C.; Tan, Y.Y.; Teixeira, M.R.; Teo, S.H.; Thomassen, M.; Tibiletti, M.G.; Tischkowitz, M.; Tognazzo, S.; Toland, A.E.; Tommasi, S.; Torres, D.; Toss, A.; Trainer, A.H.; Tung, N.; Van Asperen, C.J.; Van Der Baan, F.H.; Van Der Kolk, L.E.; Van Der Luijt, R.B.; Van Hest, L.P.; Varesco, L.; Varon-Mateeva, R.; Viel, A.; Vierstrate, J.; Villa, R.; Von Wachenfeldt, A.; Wagner, P.; Wang-Gohrke, S.; Wappenschmidt, B.; Weitzel, J.N.; Wieme, G.; Yadav, S.; Yannoukakos, D.; Yoon, S.-Y.; Zanzottera, C.; Zorn, K.K.; D’Amico, A.V.; Freedman, M.L.; Pomerantz, M.M.; Chenevix-Trench, G.; Antoniou, A.C.; Neuhausen, S.L.; Ottini, L.; Nielsen, H.R.; Rebbeck, T.R.
Other contributor: University of Helsinki, Medicum
University of Helsinki, INDIVIDRUG - Individualized Drug Therapy
University of Helsinki, HUS Gynecology and Obstetrics








Date: 2020-02-01
Language: eng
Number of pages: 15
Belongs to series: Cancer Research
ISSN: 0008-5472
DOI: https://doi.org/10.1158/0008-5472.CAN-19-1840
URI: http://hdl.handle.net/10138/325578
Abstract: Pathogenic sequence variants (PSV) in BRCA1 or BRCA2 (BRCA1/2) are associated with increased risk and severity of prostate cancer. Weevaluated whether PSVs inBRCA1/2 were associated with risk of overall prostate cancer or high grade (Gleason 8+) prostate cancer using an international sample of 65 BRCA1 and 171 BRCA2 male PSV carriers with prostate cancer, and 3,388 BRCA1 and 2,880 BRCA2 male PSV carriers without prostate cancer. PSVs in the 30 region of BRCA2 (c.7914+) were significantly associated with elevated risk of prostate cancer compared with reference bin c.1001c.7913 [HR = 1.78; 95% confidence interval (CI), 1.25-2.52; P = 0.001], as well as elevated risk of Gleason 8+ prostate cancer (HR = 3.11; 95% CI, 1.63-5.95; P = 0.001). c.756-c.1000 was also associated with elevated prostate cancer risk (HR = 2.83; 95% CI, 1.71-4.68; P = 0.00004) and elevated risk of Gleason 8+prostate cancer (HR = 4.95; 95% CI, 2.12-11.54; P = 0.0002). No genotype-phenotype associations were detected for PSVs in BRCA1. These results demonstrate that specific BRCA2 PSVs may be associated with elevated risk of developing aggressive prostate cancer. Significance: Aggressive prostate cancer risk in BRCA2 mutation carriers may vary according to the specific BRCA2 mutation inherited by the at-risk individual.
Subject: 3122 Cancers
3111 Biomedicine
MESSENGER-RNA DECAY
BREAST-CANCER
GERMLINE MUTATIONS
GENE
OVARIAN
PHENOTYPE
INCREASE
CARRIERS
APC
IDENTIFICATION
Rights:


Files in this item

Total number of downloads: Loading...

Files Size Format View
Rebbeck_PCCR_CR_Revised_8.5.2019_CLEAN.pdf 723.5Kb PDF View/Open

This item appears in the following Collection(s)

Show full item record